Skip to main content
BRVE $21.75 +1.45%
BRVE · Braveheart Bio, Inc.
Track BRVE — free
$21.75 +0.31 (+1.45%)
Market Cap
$1.93B
Shares
90.04M
Volume · Oct 26 37.05K Avg daily vol (56 sessions) 499.9K
All webcasts

Earnings call · FY2026 Q2

Braveheart Bio, Inc. (BRVE) Q2 2026 Earnings Call

Concluded Sep 30, 2026
Sep 30, 2026 0 turns
Period
FY2026 Q2
Runtime
—
Sources
2 artifacts
Diluted EPS -$2.51
Net income -$14.99M
Open full screen 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Full-screen source Call document